Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 102 citing Meier: Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives.... (0.10 sec) 

Enhancing incretin action for the treatment of type 2 diabetes

- diabetesjournals.org
DJ Drucker - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide
(GIP) exert important effects on β-cells to stimulate glucose-dependent insulin secretion. Both
peptides also regulate β-cell proliferation and cytoprotection. GLP-1, but not GIP, inhibits ...
Cited by 284 - Related articles - All 13 versions

Role of incretin hormones in the regulation of insulin secretion in diabetic and …

- physiology.org
JJ Holst, J Gromada - American Journal of Physiology- …, 2004 - Am Physiological Soc
The available evidence suggests that about two-thirds of the insulin response to an oral glucose
load is due to the potentiating effect of gut-derived incretin hormones. The strongest candidates
for the incretin effect are glucose-dependent insulinotropic polypeptide (GIP) and ...
Cited by 180 - Related articles - BL Direct - All 4 versions

Coffee consumption and risk of type 2 diabetes mellitus among middle-aged …

- ohsu.edu [PDF] 
J Tuomilehto, G Hu, S Bidel, J Lindstrom, P Jousilahti - Jama, 2004 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Only a few studies of coffee consumption ...
Cited by 154 - Related articles - BL Direct - All 9 versions

Incretins, insulin secretion and type 2 diabetes mellitus


T Vilsbøll, JJ Holst - Diabetologia, 2004 - Springer
When glucose is taken orally, insulin secretion is stim- ulated much more than it is when glucose
is infused intravenously so as to result in similar glucose con- centrations. This effect, which is
called the incretin ef- fect and is estimated to be responsible for 50 to 70% of the insulin ...
Cited by 145 - Related articles - BL Direct - All 7 versions

International Union of Pharmacology. XXXV. The glucagon receptor family

- aspetjournals.org
KE Mayo, LJ Miller, D Bataille, S Dalle, B Goke, B … - Pharmacological reviews, 2003 - ASPET
Peptide hormones within the secretin-glucagon family are expressed in endocrine cells of the
pancreas and gastrointestinal epithelium and in specialized neurons in the brain, and subserve
multiple biological functions, including regulation of growth, nutrient intake, and transit ...
Cited by 143 - Related articles - BL Direct - All 7 versions

Defective amplification of the late phase insulin response to glucose by GIP in …


T Vilsbøll, T Krarup, S Madsbad, J Holst - Diabetologia, 2002 - Springer
Aims/hypothesis. Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in patients with Type
II (non- insulin-dependent) diabetes mellitus, whereas glu- cose-dependent insulinotropic polypeptide
(GIP) is less effective. Our investigation evaluated “early” (protocol 1) – and “late phase” ( ...
Cited by 135 - Related articles - BL Direct - All 4 versions

Gastric Inhibitory Polypeptide: the neglected incretin revisited* 1


JJ Meier, MA Nauck, WE Schmidt, B Gallwitz - Regulatory peptides, 2002 - Elsevier
After the ingestion of fat- and glucose-rich meals, gut hormones are secreted into the circulation
in order to stimulate insulin secretion. This so-called “incretin effect” is primarily conferred by
Glucagon-like peptide 1 (GLP-1) and Gastric Inhibitory Polypeptide (GIP). In contrast to ...
Cited by 124 - Related articles - All 5 versions

Normalization of glucose concentrations and deceleration of gastric emptying after …

- endojournals.org
JJ Meier, B Gallwitz, S Salmen, O Goetze, JJ … - Journal of Clinical …, 2003 - Endocrine Soc
The effects of different iv doses of glucagon-like peptide 1 (GLP-1) on glucose homeostasis and
gastric emptying were compared in patients with type 2 diabetes. Twelve patients with type 2
diabetes received three different infusion rates of GLP-1 (0.4, 0.8, and 1.2 pmol/kg·min) or ...
Cited by 122 - Related articles - BL Direct - All 5 versions

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 …


DJ Drucker - eid, 2003 - informahealthcare.com
Incretins are peptide hormones, exemplified by glucose-dependent insulino- tropic peptide and
glucagon-like peptide 1 that are released from the gut in response to nutrient ingestion and enhance
glucose-stimulated insulin secre- tion. Incretin action is terminated due to N-terminal ...
Cited by 118 - Related articles - All 6 versions

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes


MA Nauck, JJ Meier - Regulatory peptides, 2005 - Elsevier
Glucagon-like peptide 1 (GLP-1) was discovered as an insulinotropic gut hormone, suggesting
a physiological role as an incretin hormone, ie, being responsible, in part, for the higher insulin
secretory response after oral as compared to intravenous glucose administration. This ...
Cited by 107 - Related articles - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google